banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Voglibose CAS 83480-29-9

Voglibose CAS 83480-29-9

CAS Tsis Yog: 83480-29-9
Cov Qauv Sib Nqus: C10H21TSIS MUAJ7
Cov Nqa Molecular: 267.28
EINECS TSIS MUAJ: N / A
MDL TSIS TAU: MFCD00865496

Txhawb tshuaj

Khoom Qhia:

Cov Khoom Npe: Voglibose CAS TSIS TAU: 83480-29-9


Txhais:

3,4-Dideoxy-4 - [[2-hydroxy-1- (hydroxymethyl) ethyl] amino] -2-C- (hydroxymethyl) -D-epiinositol;

5- (1,3-dihydroxypropan-2-ylamino) -1- (hydroxymethyl) cyclohexane-1,2,3,4-tetrol;


Tshuaj& Cov Khoom Uas Lub Cev:

Tsos: dawb rau off-dawb crystalline hmoov

Assay: NLT99.0%

Lub Ntsiab Kub: 601.9 ℃ ntawm 760 mmHg

Flash Point: 274.1 ℃

Melting Point: 162.0 ℃ ~ 163 ℃

Qhov ceev: 1.58 g / cm3

Nqe Taw Qhia Tshwj Xeeb: 1.635

Vapor Siab: 0mmHg ntawm 25 ° C

PSA: 153.64000

LogP: -2.36

Solubility: Dej (Me ntsis)

Pawg: Cov Qauv; Tshuaj / API Tshuaj Tsis Txaus / Metabolites;


Cov Ntaub Ntawv Kev Nyab Xeeb:

RTECS: NM7524600

Kev Nyab Xeeb Kev Nyab Xeeb: S36 / 37

Cov Lus Ceeb Toom Yuav Muaj: R20 / 21/22

Cov Cim Txog Kev Nyab Xeeb: Xi

HS Code: 2933990090


Cia:Muab cia rau hauv qhov chaw txias thiab qhuav zoo kaw lub thawv. Txav deb ntawm noo noo thiab muaj zog lub teeb / cua sov.


Daim ntawv thov:Α-Glucosidase inhibitor siv ua tshuaj tiv thaiv kab mob siab.

D-epi-Inositol, 3,4-dideoxy-4 - [[2-hydroxy-1- (hydroxymethyl) ethyl] amino] -2-C- (hydroxymethyl) yoj cov piam thaj yog qhov ncauj tawm ntawm cov ntshav qab zib cov tshuaj, postprandial hyperglycemia tuaj yeem txhim kho ntshav qab zib. Voglibose wave suab thaj siv tau dav thiab tsis yog tsuas yog siv rau cov muaj hnub nyoog nruab nrab thiab cov neeg laus uas muaj ntshav qab zib, rau cov neeg mob ntshav qab zib hom 2, cov neeg mob uas tsis ua haujlwm rau sulfonylureas, hyperlipidemia ntawm cov neeg mob ntshav qab zib, kev sib txuas ntawm cov leeg mob plawv-mob hlwb. cov neeg mob ntshav qab zib, sib koom ua ke, hyperinsulinemia muaj cov nyhuv curative zoo kawg li. Txij li thaum cov khoom no tsis txhawb kev muaj peev xwm ntawm insulin, nws tuaj yeem txo qhov kev phom sij ntawm postpranational hyperinsulinemia, txo cov tshuaj insulin tsis kam, thiab muaj txiaj ntsig zoo rau kev tiv thaiv thiab kev kho mob ntawm metabolic syndrome xws li kev mob plawv.


Peb lub Hoobkas tsim khoom siv Voglibose CAS 83480-29-9, cov cuab yeej paub tab, cov khoom lag luam ruaj khov, cov khoom lag luam zoo.

Tus me nyuam lub sijhawm: los ntawm Tshuag


Peb tuaj yeem muab 2,3-Dideoxy-2 - [[2-hydroxy-1- (hydroxymethyl) ethyl] amino] -4-C- (hydroxymethyl) -epi-inositol COA, N- (1,3-Dihydroxy-2 -propyl) valiolamine MOA, ROS, (1S, 2S, 3R, 4S, 5S) -5 - [(1,3-Dihydroxy-2-propanyl) amino] -1- (hydroxymethyl) -1,2,3,4 -cyclohexanetetrolMSDS thiab lwm yam kev txhawb nqa rau koj!


Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!


Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: voglibose cas 83480-29-9, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug